Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Horellou

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Human Gene Therapy|December 28, 1999
Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transferA P Bemelmans, P Horellou, L Pradier, et al.
Journal of Neurochemistry|August 1, 1988
Multiple human tyrosine hydroxylase enzymes, generated through alternative splicing, have different specific activities in Xenopus oocytesP Horellou, B Le Bourdellès, J Clot-Humbert, et al.
Journal of Neurochemistry|March 1, 1988
Analysis of the 5' region of the human tyrosine hydroxylase gene: combinatorial patterns of exon splicing generate multiple regulated tyrosine hydroxylase isoformsB Le Bourdellès, S Boularand, C Boni, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1997
Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson diseaseA Bilang-Bleuel, F Revah, P Colin, et al.
Nature Genetics|March 1, 1995
Transplantation to the rat brain of human neural progenitors that were genetically modified using adenovirusesO Sabaté, P Horellou, E Vigne, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|June 16, 2024
Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseasesG Galati, J Pique, P Horellou, et al.
Journal of Psychiatric Research|January 1, 1987
Molecular genetics of catecholamines as an approach to the biochemistry of manic-depressionJ Mallet, C Boni, S Dumas, et al.
Neuroreport|December 30, 1994
Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's diseaseP Horellou, E Vigne, M N Castel, et al.
Journal De Physiologie|January 1, 1991
Behavioural effects of genetically engineered cells releasing dopa and dopamine after intracerebral grafting in a rat model of Parkinson's diseaseP Horellou, C Lundberg, B Le Bourdellès, et al.
Nature Biotechnology|April 20, 1999
A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitorsO Corti, O Sabaté, P Horellou, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Human Gene Therapy|December 28, 1999
Brain-derived neurotrophic factor-mediated protection of striatal neurons in an excitotoxic rat model of Huntington's disease, as demonstrated by adenoviral gene transferA P Bemelmans, P Horellou, L Pradier, et al.
Journal of Neurochemistry|August 1, 1988
Multiple human tyrosine hydroxylase enzymes, generated through alternative splicing, have different specific activities in Xenopus oocytesP Horellou, B Le Bourdellès, J Clot-Humbert, et al.
Journal of Neurochemistry|March 1, 1988
Analysis of the 5' region of the human tyrosine hydroxylase gene: combinatorial patterns of exon splicing generate multiple regulated tyrosine hydroxylase isoformsB Le Bourdellès, S Boularand, C Boni, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 5, 1997
Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson diseaseA Bilang-Bleuel, F Revah, P Colin, et al.
Nature Genetics|March 1, 1995
Transplantation to the rat brain of human neural progenitors that were genetically modified using adenovirusesO Sabaté, P Horellou, E Vigne, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|June 16, 2024
Frequency and clinical relevance of MOG-antibodies in CSF in pediatric patients with MOG antibody-associated diseasesG Galati, J Pique, P Horellou, et al.
Journal of Psychiatric Research|January 1, 1987
Molecular genetics of catecholamines as an approach to the biochemistry of manic-depressionJ Mallet, C Boni, S Dumas, et al.
Neuroreport|December 30, 1994
Direct intracerebral gene transfer of an adenoviral vector expressing tyrosine hydroxylase in a rat model of Parkinson's diseaseP Horellou, E Vigne, M N Castel, et al.
Journal De Physiologie|January 1, 1991
Behavioural effects of genetically engineered cells releasing dopa and dopamine after intracerebral grafting in a rat model of Parkinson's diseaseP Horellou, C Lundberg, B Le Bourdellès, et al.
Nature Biotechnology|April 20, 1999
A single adenovirus vector mediates doxycycline-controlled expression of tyrosine hydroxylase in brain grafts of human neural progenitorsO Corti, O Sabaté, P Horellou, et al.
Pageof 4